In a significant advancement for prenatal care, Sabine Hospital in Kerala is revolutionizing the detection of genetic diseases within the womb through the introduction of the Next Generation Sequencer (NGS).
This cutting-edge technology will be a cornerstone in the hospital’s commitment to providing accessible and advanced diagnostic services to the public.
The NGS machine can identify a range of genetic conditions, including various cancers, sickle cell anaemia, haemophilia, Down syndrome, and Turner syndrome early on.
By analyzing DNA samples from fetuses, particularly those conceived via IVF treatments, the NGS can pinpoint risk factors and genetic irregularities.
The foresight provided by this technology enables healthcare providers to implement preventative measures or begin treatment at the earliest stages so that it mitigates the impact of these conditions post-birth through vigilant testing and monitoring.
This innovative equipment will installed within Sabine Hospital’s newly inaugurated genetic department, an institution to advance fetal medicine.
The department is complemented by the Fetal Medicine department, which is under the expert guidance of Dr Jitha, who ensures that pregnant women and their unborn children receive the highest standard of care and treatment.
source:
